Clinical Trials
BioSight Completed Patient Enrollment and Treatment in its Extended Acute Leukemia Phase I/II Clinical Trial
BioSight, Ltd, a pharmaceutical development company, focused on the development of targeted oncology therapeutics with reduced toxicity, announced completion of last patient treatment in...
Industry Reports
TraceLink Breaks New Record for Highest Quarterly Sales Bookings in Q2 2017
TraceLink Inc., the World’s Largest Track and Trace Network for connecting the life sciences supply chain and providing real-time information sharing for better patient...
News
selvita and the leukemia & lymphoma society announce partnership to advance sel120 into phase i for aml patients
Selvita S.A. and The Leukemia & Lymphoma Society (LLS) announced a partnership to co-fund further preclinical and clinical development of a targeted therapy to...
Articles
Cancer drug screening process saves discovery time and limits use of mice
A method of testing drugs thatprompt the immune system to attack and destroy cancer cells has been developed which can speed up drug discovering...
Press Releases
CRL from the FDA for latanoprostene bunod ophthalmic solution , received by Valeant Pharmaceuticals
Valeant Pharmaceuticals International, Inc announced it has received a CRL from the U.S. FDA regarding the NDA for latanoprostene bunod ophthalmic solution, 0.024%, an...
Clinical Trials
Kite Doses First Patient in the Phase 2 Trial of Axicabtagene Ciloleucel in Indolent B-Cell Non-Hodgkin Lymphoma
Kite Pharma, Inc , a leading cell therapy company announced that patients with relapsed/refractory indolent B-cell non-Hodgkin lymphoma (iNHL) are now being treated in...
News
FDA Issues Emergency Use Authorization for Thermo Fisher Scientific’s Zika Virus Assay
Thermo Fisher Scientific, the world leader in serving science announced that the U.S. FDA has issued an Emergency Use Authorization for the company's new...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read















